Targeting tumor-associated macrophages in cancer therapy and understanding their complexity

Por Cannarile, Michael A., Ries, Carola H., Hoves, Sabine, Rüttinger, Dominik
Publicado no Oncoimmunology (2014)

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy

Por Cannarile, Michael A., Weisser, Martin, Jacob, Wolfgang, Jegg, Anna-Maria, Ries, Carola H., Rüttinger, Dominik
Publicado no J Immunother Cancer (2017)

Transcriptional regulator Id2 controls survival of hepatic NKT cells

Por Monticelli, Laurel A., Yang, Yang, Knell, Jamie, D'Cruz, Louise M., Cannarile, Michael A., Engel, Isaac, Kronenberg, Mitchell, Goldrath, Ananda W.
Publicado em 2009

Systematic evaluation of immune regulation and modulation

Por Stroncek, David F., Butterfield, Lisa H., Cannarile, Michael A., Dhodapkar, Madhav V., Greten, Tim F., Grivel, Jean Charles, Kaufman, David R., Kong, Heidi H., Korangy, Firouzeh, Lee, Peter P., Marincola, Francesco, Rutella, Sergio, Siebert, Janet C., Trinchieri, Giorgio, Seliger, Barbara
Publicado no J Immunother Cancer (2017)

Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity

Por Hoves, Sabine, Ooi, Chia-Huey, Wolter, Carsten, Sade, Hadassah, Bissinger, Stefan, Schmittnaegel, Martina, Ast, Oliver, Giusti, Anna M., Wartha, Katharina, Runza, Valeria, Xu, Wei, Kienast, Yvonne, Cannarile, Michael A., Levitsky, Hyam, Romagnoli, Solange, De Palma, Michele, Rüttinger, Dominik, Ries, Carola H.
Publicado no J Exp Med (2018)

Implementing liquid biopsies into clinical decision making for cancer immunotherapy

Por Quandt, Dagmar, Zucht, Hans Dieter, Amann, Arno, Wulf-Goldenberg, Anne, Borrebaeck, Carl, Cannarile, Michael, Lambrechts, Diether, Oberacher, Herbert, Garrett, James, Nayak, Tapan, Kazinski, Michael, Massie, Charles, Schwarzenbach, Heidi, Maio, Michele, Prins, Robert, Wendik, Björn, Hockett, Richard, Enderle, Daniel, Noerholm, Mikkel, Hendriks, Hans, Zwierzina, Heinz, Seliger, Barbara
Publicado no Oncotarget (2017)

First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors

Por Menke-van der Houven van Oordt, C. Willemien, Gomez-Roca, Carlos, van Herpen, Carla, Coveler, Andrew L., Mahalingam, Devalingam, Verheul, Henk M. W., van der Graaf, Winette T. A., Christen, Randolph, Rüttinger, Dominik, Weigand, Stefan, Cannarile, Michael A., Heil, Florian, Brewster, Michael, Walz, Antje-Christine, Nayak, Tapan K., Guarin, Ernesto, Meresse, Valerie, Le Tourneau, Christophe
Publicado no Oncotarget (2016)